Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
NVIDIA
NVDA
|
$8.31B |
| 2 |
Apple
AAPL
|
$7.86B |
| 3 |
Salesforce
CRM
|
$2.52B |
| 4 |
UnitedHealth
UNH
|
$2.25B |
| 5 |
Meta Platforms (Facebook)
META
|
$2.2B |
Top Sells
| 1 |
Broadcom
AVGO
|
$10.3B |
| 2 |
Abbott
ABT
|
$2.78B |
| 3 |
GE Aerospace
GE
|
$2.39B |
| 4 |
Micron Technology
MU
|
$1.93B |
| 5 |
Norwegian Cruise Line
NCLH
|
$1.19B |
Sector Composition
| 1 | Technology | 27.28% |
| 2 | Healthcare | 15.12% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cencora
COR
$56.5B
| $640M | 0.14% | 2,840,117 +163,365 | +6% | +$36.8M |
|
127
Las Vegas Sands
LVS
$39.6B
| $623M | 0.14% | 14,083,602 +12,680,320 | +904% | +$561M |
|
128
Saia
SAIA
$7.9B
| $603M | 0.13% | 1,271,702 +202,370 | +19% | +$96M |
|
129
Woodward
WWD
$14.8B
| $602M | 0.13% | 3,450,898 -175,194 | -5% | -$30.6M |
|
130
Icon
ICLR
$13.8B
| $596M | 0.13% | 1,900,180 -300,237 | -14% | -$94.1M |
|
131
Sherwin-Williams
SHW
$91.2B
| $591M | 0.13% | 1,981,459 -83,688 | -4% | -$25M |
|
132
Regeneron Pharmaceuticals
REGN
$61.5B
| $587M | 0.13% | 558,787 +164,605 | +42% | +$173M |
|
133
ConocoPhillips
COP
$124B
| $578M | 0.13% | 5,054,448 -1,639,825 | -24% | -$188M |
|
134
Caterpillar
CAT
$196B
| $577M | 0.13% | 1,730,972 -289,128 | -14% | -$96.3M |
|
135
Haemonetics
HAE
$2.63B
| $572M | 0.13% | 6,915,209 +240,458 | +4% | +$19.9M |
|
136
Marsh & McLennan
MMC
$101B
| $564M | 0.12% | 2,674,606 +412,596 | +18% | +$86.9M |
|
137
Altria Group
MO
$113B
| $549M | 0.12% | 12,042,136 -2,796 | -0% | -$127K |
|
138
First Solar
FSLR
$20.9B
| $538M | 0.12% | 2,387,281 -555,309 | -19% | -$125M |
|
139
CME Group
CME
$96B
| $529M | 0.12% | 2,689,021 -951,245 | -26% | -$187M |
|
140
Humana
HUM
$36.5B
| $525M | 0.12% | +1,405,646 | New | +$525M |
|
141
Principal Financial Group
PFG
$17.9B
| $518M | 0.11% | 6,603,902 +1,604 | +0% | +$126K |
|
142
General Motors
GM
$55.8B
| $501M | 0.11% | 10,773,745 -3,086,804 | -22% | -$143M |
|
143
Monster Beverage
MNST
$60.9B
| $490M | 0.11% | 9,810,124 -688,400 | -7% | -$34.4M |
|
144
Sysco
SYY
$38.5B
| $490M | 0.11% | 6,863,384 +251,292 | +4% | +$17.9M |
|
145
Qorvo
QRVO
$8.4B
| $487M | 0.11% | 4,193,133 -398,852 | -9% | -$46.3M |
|
146
Eastman Chemical
EMN
$8.08B
| $485M | 0.11% | 4,952,102 +440,636 | +10% | +$43.2M |
|
147
British American Tobacco
BTI
$124B
| $474M | 0.1% | 15,321,220 +8,355 | +0.1% | +$258K |
|
148
CAVA Group
CAVA
$7.83B
| $458M | 0.1% | 4,940,652 -370,683 | -7% | -$34.4M |
|
149
Ferrari
RACE
$85B
| $458M | 0.1% | 1,120,280 -209,434 | -16% | -$85.6M |
|
150
LPL Financial
LPLA
$29.2B
| $440M | 0.1% | 1,577,102 -20,034 | -1% | -$5.6M |
|